Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Vänersborg – page 3

31 clinical trials in Vänersborg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Vänersborg at a glance
31
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

31 trials in Vänersborg

Open in trial search

Polycythaemia vera+10

Not recruiting

Study on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Panobinostat
  • Sponsor:Novartis Pharma Services AG

Plasma cell myeloma

Not recruiting

Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Study on the Effects of Metoprolol Tartrate for Patients with Chronic Obstructive Pulmonary Disease (COPD) Without Cardiovascular Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Metoprolol Tartrate
  • Sponsor:Region Oerebro Laen

C3 glomerulopathy

Not recruiting

Study Comparing Aliskiren and Enalapril for Patients with C3 Glomerulopathy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Aliskiren
  • Sponsor:Region Skane

Plasma cell myeloma

Not recruiting

Study on the Effectiveness of Ixazomib, Lenalidomide, and Dexamethasone in Treating Newly Diagnosed Multiple Myeloma in Patients Eligible for Transplant

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ixazomib
  • Sponsor:HUS-yhtymae

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ixekizumab
  • Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Vänersborg

What the registry says about research in the country

01 Women's Health & Cancer Prevention

Innovative research combining HPV vaccination with screening protocols to accelerate the elimination of cervical cancer. This groundbreaking approach targets women aged 23-25 through the Swedish screening program.

  • HPV infection prevention
  • Cervical cancer screening
  • Population-level intervention

The study aims to establish more effective strategies for cancer prevention through integrated healthcare approaches.

02 Respiratory Medicine

Investigation into the potential benefits of beta-blocker treatment for COPD patients without cardiovascular comorbidities, focusing on preventing exacerbations and improving outcomes.

  • COPD management
  • Cardiovascular prevention
  • Exacerbation reduction

This research explores new therapeutic approaches for chronic respiratory disease management.

03 Diabetes & Wound Care

Comparative analysis of antimicrobial treatments for diabetic foot ulcers, evaluating the effectiveness of hypochlorous acid versus Polyhexamethylene biguanide in wound healing.

  • Wound healing optimization
  • Antimicrobial therapy
  • Diabetes complications

The research focuses on improving treatment outcomes for diabetic wound care.

04 Diabetes Management

Evaluation of SGLT2 inhibitors compared to metformin in early Type 2 Diabetes, examining progression-free survival and treatment efficacy.

  • Early diabetes intervention
  • Treatment comparison
  • Disease progression

This study aims to optimize first-line treatment strategies for newly diagnosed diabetes patients.

05 Pediatric Neurology

Assessment of atogepant for migraine prevention in young patients, focusing on long-term safety and effectiveness in children aged 6-17 years.

  • Pediatric migraine treatment
  • Safety monitoring
  • Long-term outcomes

This research addresses the critical need for safe and effective migraine treatments in pediatric populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.